Shoulder Innovations (NYSE:SI) COO Sells $78,072.96 in Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 4,144 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $18.84, for a total transaction of $78,072.96. Following the transaction, the chief operating officer directly owned 269,176 shares in the company, valued at approximately $5,071,275.84. This trade represents a 1.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.68, for a total transaction of $296,190.08.

Shoulder Innovations Trading Up 3.7%

Shares of SI opened at $18.64 on Friday. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11. The firm’s 50-day moving average is $14.79 and its two-hundred day moving average is $14.44. Shoulder Innovations, Inc. has a twelve month low of $10.92 and a twelve month high of $19.79. The firm has a market capitalization of $386.59 million and a P/E ratio of -0.11.

Shoulder Innovations (NYSE:SI) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.03. The company had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. On average, research analysts predict that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

SI has been the topic of a number of research reports. Piper Sandler reissued an “overweight” rating and issued a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. BTIG Research upped their price target on shares of Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, March 11th. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $21.00.

Institutional Trading of Shoulder Innovations

Several institutional investors and hedge funds have recently made changes to their positions in SI. Bank of America Corp DE increased its position in Shoulder Innovations by 43.7% during the 1st quarter. Bank of America Corp DE now owns 26,983 shares of the company’s stock worth $392,000 after purchasing an additional 8,205 shares in the last quarter. Royal Bank of Canada lifted its holdings in Shoulder Innovations by 7,046.3% in the 1st quarter. Royal Bank of Canada now owns 53,883 shares of the company’s stock valued at $783,000 after purchasing an additional 53,129 shares in the last quarter. KCM Capital Inc acquired a new stake in shares of Shoulder Innovations during the 1st quarter worth about $509,000. Roubaix Capital LLC grew its holdings in shares of Shoulder Innovations by 61.9% during the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after buying an additional 98,305 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in shares of Shoulder Innovations in the first quarter valued at approximately $252,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.